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Wnts are a family of secreted glycoproteinswith
diverse developmental roles, including regula-
tion of cell migration; however, little is known
about wnt signaling in mature T cells. We find
that endothelial-cell-derived wnts, acting
through Frizzled receptors, induce matrix met-
alloproteinase (MMP) 2 and MMP9 expression
in effector T cells. Blocking wnt signaling, or
MMP activity, reduces T cell migration through
the basement membrane in vitro and into in-
flamed skin in vivo. Wnt signaling stabilizes b-
catenin protein in T cells and directly targets
the MMP promoters through tandem TCF sites.
Thus, our data support a necessary and previ-
ously unexpected role for wnt signaling in T
cell extravasation.
INTRODUCTION
The migration of T cells across the endothelial cell (EC)
barrier that separates blood from tissue represents a criti-
cal event in inflammation, and the failure of this process,
due to the lack of necessary recognition molecules, can
result in recurrent infections and failure to clear pathogens
(Madri and Graesser, 2000). The extravasation process in-
volves complexmorphological changes in both T cells and
ECs, as well as multiple interactions between cell-cell and
cell-matrix adhesion molecules. Although the specifics of
T cell recruitment are not well understood, the basic
mechanism of extravasation employed by other leuko-
cytes, in particular neutrophils and macrophages, has
been described thusly: Selectins mediate the initial cap-
ture of the leukocyte and the rolling phase; leukocyte ar-
rest and firm adhesion are then triggered by EC-
expressed chemokines that induce integrins to assume a
high-affinity state. Less well understood are the molecular
cues underlying the induction of morphological changes
and the initiation of new gene expression that are associ-
ated withmigration across the ECmonolayer, degradation
of the underlying basement membrane (BM), and subse-
quent movement along chemokine gradients within the in-
terstitial matrix. Progress has been made in our under-
standing of diapedesis, where the leukocyte squeezesbetween adjacent ECs, through studies on monocyte
migration where both platelet-endothelial cell adhesion
molecule-1 (PECAM-1, CD31) and CD99 have been impli-
cated (Muller, 2003). It is not known whether identical or
similar processes regulate T lymphocyte transmigration.
The BM, composed largely of collagen type IV, laminin,
nidogen, fibronectin, and perlecan (Baluk et al., 2003),
represents a major barrier to migrating T cells and neces-
sitates the inducible expression by migrating cells of
several proteases including matrix metalloproteinase-2
(MMP2) andMMP9, also known as gelatinase A and B, re-
spectively (Goetzl et al., 1996; Madri and Graesser, 2000).
These can be induced by T cell receptor triggering in vitro;
however, it is not known in vivo what the major inducing
signal is or when and where expression is induced. One
possibility is that MMP expression is induced by interac-
tion with the EC, and vascular cell adhesion molecule-
very late antigen-4 (VCAM-VLA-4) interaction has been
implicated in different settings (Madri et al., 1996; Ro-
manic et al., 1997). Numerous studies have demonstrated
the importance of MMP activity in T cell migration in vivo.
For example, the MMP inhibitor a-lipoic acid blocked T
cell migration into the spinal cord (Marracci et al., 2002),
astilbin was suggested to block delayed-type hypersensi-
tivity (DTH) responses in mice by inhibiting MMP activity
and lymphocyte migration (Cai et al., 2003), and MMP2
and MMP9 were shown to be essential for T cell migration
into the lung in an allergen-induced airway inflammation
model (Kumagai et al., 1999). T cell-associatedMMPactiv-
ity has also been implicated in the pathogenesis of exper-
imental autoimmune encephalomyelitis (EAE) (Graesser
et al., 1998; Madri and Graesser, 2000; Madri et al.,
1996; Sixt et al., 2001). Notably, specific degradation of
laminin10 has been correlated with efficient migration of
encephalitogenic T cells into the brain parenchymaofmice
in an EAE model (Sixt et al., 2001). Finally, MMPs may not
only promote T cellmigration bydegradingmatrix aheadof
the cell but may also influence the local free concentration
of chemokines (Li et al., 2002). Interestingly,MMP7 is awnt
target in colon cancer (Crawford et al., 1999), and wnts
havebeen implicated in cellmigration andmetastasis (Hei-
senberg et al., 2000; Qiang et al., 2005; Weeraratna et al.,
2002).Wnt signaling is necessary for proper T cell develop-
ment (see below) and also regulates NFAT localization in
mature T cells (Salazar Murphy and Hughes, 2002). Taken
together, these findings raise the possibility that wnts may
regulate MMP expression in T cells.Immunity 26, 227–239, February 2007 ª2007 Elsevier Inc. 227
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Wnt Regulation of T Cell MigrationFigure 1. Endothelial Cells Induce b-Catenin-Dependent Wnt Signaling in T Cells
(A) Effector T cells were treated for the indicated times with either 10 mM Li+ or Na+ or with control or wnt3A-conditioned medium and harvested for
immunoblotting with an antibody against b-catenin. For confirmation of equal loading, blots were stripped and reprobed for a-tubulin. One of at least
three similar experiments is shown.
(B) Effector T cells were transfected with the TOPflash reporter vector and then incubated with either 10 mM Li+ or Na+ or with control or wnt3A-con-
ditionedmedium. Luciferase activity was assayed after 24 hr.Mean and SD of triplicate wells, *p < 0.005 (t test) for Na+ versus Li+, and p < 0.005 (t test)
for L-CM versus wnt3A-CM. One of three similar experiments is shown.228 Immunity 26, 227–239, February 2007 ª2007 Elsevier Inc.
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Wnt Regulation of T Cell MigrationNumerous developmental processes, as diverse as
cell-fate specification, induction of polarity, and cell mi-
gration are controlled by the wnt family of secreted glyco-
proteins (Gordon and Nusse, 2006; Logan and Nusse,
2004; Moon et al., 2004; Nusse, 2002; Wodarz and Nusse,
1998). The best understood wnt signaling pathway is de-
pendent upon the transcriptional coactivator b-catenin
(Nusse, 2002). As a result of wnt signaling, b-catenin is
translocated to the nucleus where it binds T cell factor
(TCF) family proteins and thus converts them into tran-
scriptional activators (Barker et al., 2000; Wodarz and
Nusse, 1998). In the absence of b-catenin, TCF binds to
DNA and acts as a negative regulator by recruiting the
corepressor groucho. In the absence of wnt, cytoplasmic
b-catenin forms a complex with axin and adenomatous
polyposis coli (APC) where it becomes a target for phos-
phorylation by the GSK-3b kinase and degradation by the
proteosome. Upon wnt ligation to the receptor Fz and the
coreceptor LRP, the modular protein disheveled (Dsh in
flies, Dvl in mammals) binds to the b-catenin-Axin-APC
complex and reduces the activity of GSK-3b toward b-cat-
enin. The accumulated b-catenin can then translocate to
the nucleus and modulate TCF-dependent transcription
(Moon, 2002). Examples of wnts that signal through this
pathway include wnt1, wnt2B, wnt3A, and wnt8B.
Previous studies on wnt signaling in T cells have largely
focused on thymocyte development (Held et al., 2003;
Ioannidis et al., 2001; Pongracz et al., 2006; Staal and
Clevers, 2005; Staal et al., 2004). LEF-1 and TCF-1 are ex-
pressed in thymocytes, where they drive expression of
CD4 (Huang et al., 2006). TCF-deficient mice have a block
at the immature single positive (ISP) to double-positive
transition because of a block in ISP proliferation (Schilham
et al., 1998). Evidence that this reflects a direct role for
wnts in thymocyte development comes from studies on
wnt-deficient mice. Although mice deficient for either
wnt1 (McMahon and Bradley, 1990) or wnt4 (Stark et al.,
1994) die within 24 hr of birth, thymocytes can be recov-
ered. In the absence of either wnt1 or wnt4, there is a de-
crease of 20%–30% in cell number and a loss of over 70%
in the double knockout (Mulroy et al., 2002).
We previously showed that a non-b-catenin-dependent
wnt pathway is active in T cells and mediates NFAT local-
ization (Salazar Murphy and Hughes, 2002). Here, we
show that b-catenin-dependent wnt signaling is also
active in mature, peripheral blood T cells and that EC-Imderived wnts induce MMP expression and augment
T cell transmigration, both in vitro and in vivo. Thus, our
data demonstrate a previously unrealized role for wnt
signaling in the biology of mature T cells.
RESULTS
Wnt Signaling Is Active in Mature T Cells
Previous studies have failed to detect b-catenin protein
in mature T cells, suggesting the absence of b-catenin-
dependent wnt signaling (Chung et al., 2002). However,
no attempt wasmade to stabilize b-catenin protein. In light
of our previous studies showing a role for the Ca2+ and
protein kinaseC (PKC)-dependent wnt pathway in regulat-
ing NFAT localization in mature T cells (Salazar Murphy
and Hughes, 2002), we decided to readdress the issue
of b-catenin-dependent signaling, which uses some of
the same receptors, in these cells. By immunoblotting,
we found that both Li+ and wnt3A-containing conditioned
medium (wnt3A-CM) led to the accumulation of b-catenin
protein in effector T cells (Figure 1A). Li+ directly inhibits
GSK-3b activity, whereas wnt3A acts upstream through
Frizzled (Fz) receptors.
To determine whether this stabilized b-catenin protein
was active, we employed the wnt reporter TOPflash,
which consists of multimerized TCF-binding motifs up-
stream of the luciferase gene (Korinek et al., 1997). The
FOPflash control vector contains mutated binding sites
and was used as a negative control. Consistent with the
stabilization of b-catenin protein, both Li+ and wnt3A-
CM strongly activated TOPflash in effector T cells (Fig-
ure 1B). TOPflash but not FOPflash activity was also in-
creased in T cells expressing either wnt1 or a constitutively
active form of b-catenin (S33Y) that has a targeted muta-
tion of the serine phosphorylated byGSK-3b (Figure 1C). It
is important to note that wnt1 andwnt3A are considered to
be functionally redundant (see Discussion).
Axin, along with APC, performs a critical scaffolding
function in the targeting of b-catenin for phosphorylation
by GSK-3b, and overexpression of axin has previously
been shown to disrupt wnt signaling (Nakamura et al.,
1998). We confirmed this finding in T cells, where coex-
pression of axin reduced wnt1-induced TOPflash activity
by almost 40% (Figure 1D). Taken as a whole, these re-
sults confirm that a functional b-catenin wnt pathway is
present in both resting and effector T cells.(C) The left graph shows effector T cells that were transfected with either the TOPflash reporter or the control FOPflash, which contains mutated TCF
binding sites, along with an expression plasmid for wnt1. The right graph shows effector T cells that were transfected with the TOPflash reporter along
with expression vectors for either wnt1 or constitutively active (CA) b-catenin (CA-b-catenin). Luciferase activity was assayed after 24 hr. Mean and
SD of triplicate wells, *p < 0.005 (t test) for GFP versus wnt1 (TOPflash) and p < 0.005 (t test) for GFP versus wnt1 or GFP versus CA-b-catenin. One of
three similar experiments is shown.
(D) Effector T cells were transfected with TOPflash and expression plasmids for wnt1 or axin as indicated. DNA load was balanced with control plas-
mid. Mean and SD of triplicate wells, *p < 0.005 (t test) for wnt1 versus wnt1 + axin. One of three similar experiments is shown.
(E) Effector T cells were transfected with TOPflash and incubated with ECs for 24 hr before assay of luciferase activity. Mean and SD of triplicate wells,
*p < 0.005 (t test). One of three similar experiments is shown.
(F) Effector T cells were transfected with TOPflash and incubated with ECs expressing sFz5 or wnt1 as indicated. DNA load was balanced with control
plasmid. Luciferase activity was assayed after 24 hr. Mean and SD of triplicate wells, *p < 0.005 (t test) for GFP versus sFz5, GFP versus wnt1, and
wnt1 versus wnt1 + sFz5. Expression of tagged-sFz5 was confirmed by immunoblotting with a Flag antibody. One of at least three similar experiments
is shown.munity 26, 227–239, February 2007 ª2007 Elsevier Inc. 229
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Wnt Regulation of T Cell MigrationMature T Cells Express Multiple Proximal
Components of the Wnt Signaling Pathway
Wnt signals that act to stabilize b-catenin work through
a receptor complex composed of a frizzled family member
and either lipoprotein receptor-related protein-5 (LRP5) or
LRP6 (Tamai et al., 2000). This complex is then thought to
trigger the translocation of dvl to the axin-APC-GSK-3b
complex. We investigated the expression of Fz, LRP,
and dvl in mature T cells by semiquantitative RT-PCR
looking at both resting and effector T cells. Notably, all
of the frizzleds present in resting T cells (Fz3, Fz4, Fz5,
Fz6, and Fz7) were strongly upregulated in effector T cells
(Table 1). LRP5 was also upregulated, in contrast to LRP6,
which showed substantially decreased expression. Be-
cause antibodies specific for thesemolecules are currently
unavailable, we were not able to confirm these findings
by immunoblotting. All three dvl genes were expressed
at roughly comparable amounts between resting and ef-
fector T cells. The correlation between T cell activation
and upregulation of wnt receptors suggested that wnt sig-
naling may be particularly important in effector cells, and
because of their obvious functional importance, all subse-
quent experiments were performed with effector T cells.
Endothelial Cells Induce Wnt Signaling in T Cells
During circulation throughout the body, T cells continu-
ously come into contact with the ECs that line blood ves-
sels. Naive T cells recirculate through the lymph nodes
bycrossing thehigh-endothelial venules,whereasmemory
and effector T cells followamore complex path, by homing
both to lymphnodes and then,when reactivated, to sites of
infection or inflammation. Because previous reports have
suggested that ECs express various wnts (Cheng et al.,
2003; Wright et al., 1999), we hypothesized that EC-
derived wnts might activate signaling in T cells and partic-
ularly in effector T cells, which express elevated amounts
of Fz receptors. As a first step to testing this hypothesis,
we examined wnt expression by cultured ECs with semi-
quantitative RT-PCR. Transcripts were detected for sev-
eral wnts, including wnt1, wnt2B, wnt4, wnt5A, and
wnt8B (data not shown). Again, because of the lack of spe-
cific reagents we were not able to confirm these results at
the protein level. However, to determine whether EC-de-
rived wnts are functional, we transfected effector T cells
with the TOPflash wnt reporter and incubated them with
ECs. ECs dramatically enhanced luciferase expression in
T cells, as measured by a 40-fold increase in TOPflash ac-
tivity (Figure1E). Thus,EC-derivedwntsare fully capableof
inducing b-catenin-dependent signaling in effector T cells.
The specificity of wnt-Fz interactions remains unclear.
An individual wnt can bind to multiple Fzs, and a single
Fz may recognize multiple wnts (Wodarz and Nusse,
1998). Thus, to block wnt signaling, we generated an ex-
pression construct encoding the extracellular, cysteine-
rich domain (CRD) of Fz5 (Salazar Murphy and Hughes,
2002) and confirmed expression by western blotting
(Figure 1F). We then demonstrated that this protein could
act as a dominant negative to block EC-derived wnts from
activating signaling in T cells (Figure 1F). Overexpression230 Immunity 26, 227–239, February 2007 ª2007 Elsevier Inc.of soluble Fz5 (sFz5) in ECs inhibited TOPflash activation
in cocultured effector T cells by 45%. sFz5 also reduced
TOPflash activation induced by overexpressing wnt1 in
ECs to a similar degree (Figure 1F). Thus, EC-derived wnts
can stimulate b-catenin-dependent wnt signaling in cocul-
tured effector T cells, and this can be blocked by sFz5.
Wnt Signaling Regulates T Cell Transmigration
Based both on our finding that ECs induce wnt signaling in
effector T cells and on the known role of wnts in cell migra-
tion and metastasis (Muller et al., 2002; Ouko et al., 2004;
Weeraratna et al., 2002), we hypothesized that EC-derived
wnts might regulate the extravasation of effector T cells—
either by increasing T cell motility or by facilitating egress
across the EC monolayer and through the underlying ex-
tracellular matrix. To test this hypothesis, we established
an in vitro transmigration assay. Effector T cells migrate
across an ECmonolayer and through the collagen-coated
Transwell into the lower well in response to the chemokine
SDF1a. In the presence of control-transfected ECs, ap-
proximately 70% of the T cells crossed into the lower
well by 24 hr. In the presence of ECs expressing sFz5,
however, migration was reduced by 40%–60% (Fig-
ure 2A). Similar results were obtained with sFz6 (data
not shown). ICAM-1 is critically involved in T cell-EC inter-
actions, and an anti-ICAM-1, used as a positive control,
reduced migration by 80%. In addition to using sFz5 se-
creted by transfected ECs, we also used a sFz5-Fc pro-
tein, purified over protein G columns from supernatants
of transfected HEK293 or purchased from R & D Systems.
We confirmed purification of both proteins by Coomassie
blue staining (Figure 2B). Compared to the control protein
(BSA), purified sFz5-Fc significantly reduced T cell migra-
tion, by up to 80% (Figure 2C). Similar data were obtained
Table 1. T Cells Express Components of the Wnt
Signaling Pathway
Resting Effector
Fz3 + +++
Fz4 + +++
Fz5 + +++
Fz6 + +++
Fz7 + +++
LRP5 + +++
LRP6 +++ +
Dvl1 + +
Dvl2 + +
Dvl3 + +
Expression of Frizzled, LRP, and Dvl family members was ex-
amined by semiquantitative RT-PCR. Resting and effector T
cells were prepared as described in Experimental Proce-
dures. The relative expression of each gene can be compared
between resting and effector cells but not between different
genes.
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Wnt Regulation of T Cell MigrationFigure 2. Blocking Wnt Signaling with
sFz5 Reduces T Cell Transmigration
(A) ECs were transfected with 0.5 mg of GFP or
sFz5 (shown on left) or 1 mg of GFP or sFz5
(shown on right), grown to confluence on colla-
gen I-coated inserts and then stimulated with
TNF-a (10 ng/ml) for 4 hr so that expression
of adhesion molecules could be induced. Ef-
fector T cells were plated in the upper well in
the presence of HB64 () or anti-ICAM-1
mAb (shown on left). SDF1-a (100 ng/ml) was
added to the lower well. Cells that transmi-
grated into the lower well after 24 hr were
counted. Results are representative of more
than three independent experiments. Mean
and SD of triplicate wells, *p < 0.05 (t test) for
GFP versus sFz5, and p < 0.005 (t test) for
the control versus anti-ICAM-1 mAb.
(B) Coomassie blue staining of an SDS-PAGE
gel showing purified sFz5-Fc produced in
HEK293 cells (lane 2) or purchased (lane 3). Su-
pernatant from transfected HEK293 cells prior
to purification is shown in lane 1. MW markers
are in lane 4.
(C) Effector T cells were added to untrans-
fected EC monolayers in the presence of 10
mg/ml BSA or sFz5-Fc protein. Transmigrated
T cells were counted after 24 hr. Mean and
SD of triplicate wells, *p < 0.005 (t test) for the
control (0 mg/ml sFz5-Fc, 10 mg/ml BSA) versus
10 mg/ml sFz5-Fc. One of three similar experi-
ments is shown.
(D) Mice were injected i.d. on the back with
TNFa (10 ng) and IFNg (300 U), or with TNF +
IFNg along with BSA or sFz5-Fc (1 mg each).
Controls received vehicle (PBS) alone, and all
injections were in a total volume of 10 ml. Skin
was harvested after 22 hr and frozen. Sections
were stained for CD3 (green) to show T cells
and CD31 (red) to highlight blood vessels. Six
fields from duplicate sites from each mouse
were analyzed (blinded) for each condition.
Mean and SD, *p < 0.01 (t test) for BSA + cyto-
kine versus sFz5-Fc + cytokine. One of five
similar experiments is shown.
(E) Representative sections stained for T cell
CD3 (green) and EC CD31 (red). Conditions
are as indicated.with bacterially expressed sFz5 (data not shown). These
findings are fully consistent with a necessary role for wnt
signaling in T cell transmigration. The longer migration
times in vitro compared to estimated transit times in vivo
are likely due to the greater-than-10-fold difference in dis-
tance the T cells must travel (membranes are 50 mm thick
without the collagen coating and considerably thicker
with, whereas venular wall and BM thickness is <5 mm).
Soluble Fz5 Inhibits T Cell Migration into Inflamed
Tissues In Vivo
In the in vitro migration assay, we found that sFz5 blocked
T cell migration across a monolayer of ECs and through
a collagenmatrix. To test whether wnt signaling has a sim-
ilar role in vivo, we used a cytokine-induced inflammation
model, which has been previously described (Kulidjianet al., 2002). Intradermal injection of TNF-a and IFN-g re-
producibly induces a T cell-rich cutaneous inflammation.
We injected sFz5-Fc protein or BSA control protein to-
gether with the cytokines into mouse dorsal skin. After
22 hr, the skin was collected and immunofluorescence
staining was performed on frozen sections for T cells
(CD3, shown in green) and blood vessels (CD31, shown
in red). In the absence of cytokines, few infiltrating T cells
were apparent, whereas cytokines induced a robust 8- to
9-fold increase (Figure 2D). Injection of cytokines in the
presence of control protein led to a similarly pronounced
T cell infiltration (Figures 2D and 2E). In sharp contrast, co-
injection of sFz5-Fc dramatically decreased cytokine-
induced T cell infiltration, by an average of 75% (Figures
2D and 2E). Similar results were obtained with purified,
bacterially expressed, sFz5 (data not shown). Thus, wntImmunity 26, 227–239, February 2007 ª2007 Elsevier Inc. 231
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Wnt Regulation of T Cell MigrationFigure 3. Wnt Signaling Is Sufficient to
Augment T Cell Migration
(A) Effector T cells were added to subconfluent
COS-7 cells expressing wnt1 and growing on
collagen-coated wells. SDF1-a (100 ng/ml)
was added to the lower well, and cells that
had transmigrated after 24 hr were counted.
Mean and SD of triplicate wells, *p < 0.05
(t test). One of three similar experiments is
shown.
(B) Effector T cells were added to collagen-
coated wells in the presence of the control or
wnt3A-conditioned medium. SDF1-a was
added to the lower well, and cells that had
transmigrated after the indicated times were
counted. Mean and SD of triplicate wells; t
test results were as follows: For collagen I:
*p < 0.005 (12 hr) and *p < 0.02 (24 hr); for
collagen IV: *p < 0.05 (12 hr) and *p < 0.005
(24 hr). One of three similar experiments is
shown.
(C) Effector T cells were transfected with ex-
pression vectors for GFP, CA-LRP6, or CA-
b-catenin and added to collagen IV-coated
wells 24 hr after transfection. SDF1-a was
added to the lower well, and cells that had
transmigrated were counted. Mean and SD of
triplicate wells; t test results are as follows:
for GFP versus CA-LRP6: *p < 0.005; for GFP
versus CA-b-catenin: *p < 0.05. One of three
similar experiments is shown. Transfected
cells consistently migrate at a lower rate than
nontransfected cells.signaling is necessary for optimal T cell transmigration,
both in vitro and in vivo.
To determine whether wnt signaling is sufficient for aug-
menting T cell migration, we assayed migration in the
presence of subconfluent wnt1-expressing COS-7 cells.
Consistent with a role for wnts in enhancing T cell migra-
tion, wnt1 increased the number of transmigrated T cells
2- to 3-fold (Figure 3A). Similarly, wnt3A-CM also dramat-
ically augmented T cell migration through both interstitial
collagen, type I, and basement membrane collagen,
type IV (Figure 3B). Importantly, wnt3A-CM did not affect
proliferation or survival of effector T cells over the course
of 24 hr (data not shown). To determine specifically
whether b-catenin-dependent wnt signaling is sufficient
for enhancing migration, we used an N-terminal deletion
of the LRP5 (constitutively active [CA]-LRP5) receptor
and CA-b-catenin. Deletion of the extracellular, N-terminal
domain of the LRPs has previously been shown to consti-
tutively activate b-catenin-dependent signaling (Tamai
et al., 2004). Overexpression of either of these constructs
in effector T cells significantly increasedmigration through
collagen gels (Figure 3C). Thus, b-catenin-dependent sig-
naling is sufficient for upregulating T cell migration.
Wnt Signaling Induces MMP Expression in T Cells
We considered two hypotheses to explain the effect of
wnts on T cell migration: one, that wnts increase the inher-
ent motility of effector T cells, and such a finding would be232 Immunity 26, 227–239, February 2007 ª2007 Elsevier Inc.consistent with previous reports on the role of wnts in in-
ducing cell motility in other systems (Muller et al., 2002;
Ouko et al., 2004; Weeraratna et al., 2002); and two, that
wnts induce a T cell phenotype that allows the cells to
cross the EC and underlying collagen-rich basement
membrane; an obvious candidate for such a phenotype
would be induction of MMP expression. To test the first
hypothesis, wemonitored in real-time the motility of effec-
tor T cells on a 2D collagen IV matrix in the presence of the
control or wnt3A-CM. A plot of mean displacement versus
the square root of time gave a roughly linear relationship
for each group, indicating that individual T cells followed
random tracks (Figure S1 in the Supplemental Data avail-
able online). Thirty cells were randomly selected for
cell-track and velocity measurements. We noted only
a moderate, 18% increase in mean instantaneous velocity
in the presence of wnt3A-CM (5.88 mm  min1 in
wnt3A-CM compared to 4.98 mm  min1 in control me-
dium. n = 1200, p < 0.01), suggesting that the effect of
wnts on T cell transmigration cannot be accounted for
solely by increases in inherent motility.
Importantly, we found that the effect of wnts on effector
T cell migration is collagen dependent because wnt3A did
not increase migration of T cells across noncoated mem-
branes (Figure S2). Thus, we favor the second explanation
that wnts induce a T cell phenotype conducive to migra-
tion through collagen. It has been suggested previously
that T cell migration through collagen gels is independent
Immunity
Wnt Regulation of T Cell MigrationFigure 4. Wnt Signaling Induces MMP Expression
(A) Effector T cell migration is protein synthesis dependent. Effector T
cells were plated in collagen IV-coated wells in the presence of wnt3A-
conditioned medium and allowed to migrate for 24 hr in response to
SDF1-a (100 ng/ml) in the lower well. Cycloheximide or vehicle was
added at the indicated concentrations.Mean and SD of triplicatewells,
*p < 0.05 (t test) for all concentrations versus the control. One of two
similar experiments is shown.
(B) Resting or effector T cells were transfected with expression plas-
mids for either GFP or wnt1 and harvested for semiquantitative RT-
PCR analysis 24 hr later. Results are shown for MMP2 and GAPDH.
One of three similar experiments is shown.
(C) Effector T cells were allowed to migrate through collagen IV-
coated wells in the presence of the control or wnt3A-conditioned
medium as described in Figure 3. Migrated T cells were harvested,
and equal numbers were used for semiquantitative RT-PCR. Results
for MMP9 and GAPDH, in the presence or absence of reverse
transcriptase (RT), are shown. One of three similar experiments is
shown.
(D) Effector T cells were allowed to migrate through monolayers of
ECs expressing either GFP or sFz5 and were then analyzed forIof collagen degradation (Wolf et al., 2003). However, those
studies used a very low concentration of collagen (1.67
mg/ml), whereas basement membrane and interstitial col-
lagen are much denser (10–40 mg/ml [Helary et al., 2006;
Roeder et al., 2002]), andmigration through themmaywell
require MMP expression, consistent with previous find-
ings of a role for MMPs in T cell extravasation in vivo
(Cai et al., 2003; Graesser et al., 1998; Kumagai et al.,
1999; Marracci et al., 2002; Sixt et al., 2001). As an initial
test of the requirement for new protein synthesis in wnt-
induced migration, we assessed the ability of T cells
treated with the protein synthesis inhibitor cycloheximide
(CHX) to migrate through collagen gels in response to
wnt3A stimulation. Even at low concentrations, CHX dra-
matically inhibited effector T cell migration (Figure 4A),
and this reveals the necessity for protein synthesis, con-
sistent with a role for wnt-induced MMP expression.
MMP7 and MMP26 are known target genes of the b-
catenin-dependent wnt pathway in other cells (Crawford
et al., 1999; Marchenko et al., 2002); however, they are
not expressed by T cells. Instead, T cells express primarily
MMP2 and MMP9 (Madri et al., 1996). To test for wnt in-
duction of MMP2, we transfected either resting or effector
T cells with a wnt1 expression plasmid or a control plas-
mid and harvested RNA for analysis by semiquantitative
RT-PCR. MMP2 was not expressed in control resting T
cells but was strongly induced by wnt1 (Figure 4B). Effec-
tor T cells expressed MMP2 and this was upregulated by
wnt1, confirming that MMP2 is indeed a wnt target gene in
T cells. These results were confirmed by qRT-PCR, which
showed a 6-fold induction of MMP2 by wnt3A (Figure S3).
It is also important to know howmigration through the col-
lagen gel affects wnt-induced MMP expression because
interactions with matrix molecules are known to modulate
gene expression triggered by other pathways (Hood and
Cheresh, 2002; Jolivet et al., 2005; Schwartz and Gins-
berg, 2002). To examine this, we collected effector T cells
that had migrated through a collagen-IV-coated Transwell
in the presence of either the control or wnt3A-CM and ex-
aminedMMP9 expression by semiquantitative RT-PCR. In
the control-treated cells, no transcripts for MMP9 were
detectable (Figure 4C); however, the fact that a robust sig-
nal was detected in cells that hadmigrated in the presence
of wnt3A suggests that in effector T cells, MMP9 is also
a wnt target. To confirm that induction of MMP expression
by ECs is dependent on wnt signaling, we collected T cells
that had migrated through GFP- or sFz5-expressing EC
monolayers and examined MMP expression by RT- and
qRT-PCR. As before, sFz5 reduced T cell migration by
over 30% (data not shown). The suppression of wnt sig-
naling by sFz5 also significantly reduced MMP9 expres-
sion, by close to 50% (Figure 4D). qRT-PCR analysis con-
firmed this result, by showing a decrease of 52%. Addition
of purified sFz5 also strongly blocked wnt induced MMP2
and MMP9 expression (data not shown). These findings
MMP9 expression by semiquantitative RT-PCR. Mean and SD of
triplicate RT-PCR samples are shown; *p < 0.005 (t test) for GFP ver-
sus sFz5. One of three similar experiments is shown.mmunity 26, 227–239, February 2007 ª2007 Elsevier Inc. 233
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Wnt Regulation of T Cell MigrationFigure 5. Wnt Signaling Regulates MMP Expression at the Transcriptional Level
(A) Effector T cells were transfected with MMP2-Luc along with either a control or wnt1 expression plasmid and harvested 24 hr later for analysis of
luciferase expression. Mean and SD for triplicate wells, *p < 0.005 (t test). One of more than three similar experiments is shown.
(B) Effector T cells were transfected with MMP9-Luc along with either a control vector or expression vectors for wnt1, LRP5-DN, or LRP6-DN. Cells
were harvested 24 hr later for analysis of luciferase expression. Mean and SD for triplicate wells, *p < 0.005 (t test) for control versus LRP5-DN or
LRP6-DN, or control versus wnt1. One of three similar experiments is shown.
(C) Effector T cells were transfected with expression vectors for GFP, wnt3A, or CA-LRP5 along with either the wild-type (WT) or mutant MMP2 pro-
moter luciferase reporters. The promoter was mutated at both the upstream and downstream putative TCF sites. Cells were assayed for luciferase
activity at 17 hr. Reduced activity of the mutant promoter is relative to the GFP control (indicated by dotted line). One of four similar experiments is
shown.
(D) Effector T cells were transfectedwith expression vectors for GFP or wnt1, alongwith either thewild-type (WT) ormutantMMP9promoter luciferase
reporters. The promoter was mutated at both of the proximal putative TCF sites in the truncated (800 bp) promoter. Cells were assayed for luciferase
activity at 17 hr. Reduced activity of the mutant promoter is relative to the GFP control (indicated by dotted line). One of three similar experiments is
shown.
(E) Schematic of the MMP2 promoter showing the two putative TCF sites.234 Immunity 26, 227–239, February 2007 ª2007 Elsevier Inc.
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control of EC-derived wnts.
MMPs Are Transcriptional Targets of Wnt
We next asked whether MMP2 and MMP9 are transcrip-
tional targets of wnt signaling in T cells. We cloned a 1.9
kb fragment of the human MMP2 proximal promoter and
a 2.1 kb fragment of the MMP9 proximal promoter into
the pGL3-Luc reporter vector and examined their activity
in effector T cells. Both promoters responded strongly to
activation by wnt1 (Figures 5A and 5B). To determine
whether the promoters are responsive to b-catenin-
dependent signals, we cotransfected T cells with the
MMP9 reporter and expression constructs for either
constitutively active (CA)-LRP5 (LRP5-DN) or CA-LRP6
(LRP6-DN). These constructs strongly activated the
MMP9 reporter (Figure 5B), as well as the MMP2 reporter
(Figure S4), confirming that both genes are transcriptional
targets of the wnt-b-catenin pathway in T cells.
Further, in silico, analysis of the promoters revealed two
putative TCF-binding sites in the MMP2 proximal pro-
moter and four in the MMP9 proximal promoter (Figures
5E and 5F). To determine the requirement for these sites,
we generated mutations in these sites and tested the re-
sultant promoters for responsiveness to wnt signals.
Both sites in the MMP2 promoter were mutated, either
alone or in combination, so as to destroy the core CTTTG
motif. The MMP9 promoter was truncated between the
two pairs of sites, and the remaining two (proximal) TCF
sites were mutated as described for MMP2. Mutation of
these sites in either promoter strongly reduced respon-
siveness townt or to CA-LRP5 (Figures 5C and 5D). Induc-
tion of MMP2 was blocked by 65%–75% relative to GFP
control, whereas MMP9 was blocked by 65% relative to
GFP. These results confirm that the TCF sites are neces-
sary for promoter responsiveness to wnt signaling; how-
ever, they leave open the possibility that other sites are
also important.
To test whether the promoters are direct targets of the
wnt pathway, we performed chromatin immunoprecipita-
tion (ChIP) assays.We used a b-catenin antibody to immu-
noprecipitate DNA capable of binding b-catenin in vivo
and amplified this by using primers specific for the follow-
ing: a fragment of the MMP2 promoter containing the two
putative TCF-binding sites; two separate fragments of the
MMP9 promoter, containing the two pairs of sites; and
a fragment of chromosome four, which acted as a negative
control. As shown in Figure 5G, neither the specific nor
preimmune serum precipitated the negative control
DNA. In contrast, the b-catenin antibody immunoprecipi-
tated both the MMP2 and MMP9 promoters (Figures 5Hand 5I; data not shown), although the signal for MMP9
was weaker. Wnt induced an 18-fold increase in signal
for MMP2 (Figure 5J) and an 18- to 20-fold increase in sig-
nal for MMP9 (proximal sites, Figure 5K). A similar signal
was obtained for the second set of MMP9 primers (data
not shown). Further ChIP experiments (not shown) also
confirm the presence of LEF or TCF bound to the MMP2
and MMP9 promoters. We conclude, therefore, that both
the MMP2 and MMP9 proximal promoters bind a tran-
scription factor complex composed of b-catenin and ei-
ther LEF or TCF and that these two genes are thus direct
targets of the wnt signaling pathway.
MMP Activity Is Necessary for Wnt-Enhanced T Cell
Transmigration
Finally, to test explicitly whetherMMP activity is necessary
for Wnt-induced T cell migration through the collagen ma-
trix, we employed twoMMP inhibitors. OA-Hy has a broad
specificity with a Ki for MMP2 of 1.7 mM, whereas inhibitor
IV has higher specificity for MMP2 and MMP9 (MMP2 Ki =
13.9 nM; MMP9 Ki = 600 nM). Both inhibitors effectively
blocked T cell migration augmented by Wnt3A (Figures
6A and 6B), demonstrating that MMP activity is necessary
for the wnt-induced effects on T cell migration.
DISCUSSION
We have identified a unique mechanism for regulation of T
cell migration through collagen. EC-derived wnts trigger
upregulation of MMP2 and MMP9 in effector T cells and
thus enhance their ability to cross the subendothelial
basement membrane and migrate through the underlying
interstitial collagen. A soluble form of the wnt receptor Fz5
(sFz5-Fc) blocks wnt-dependant MMP induction and in-
hibits T cell transmigration in vitro and T cell extravasation
in vivo.
The early stages of leukocyte extravasation have been
described (Alon and Feigelson, 2002; Steeber and Tedder,
2000); however, it is still unclear whether the mechanisms
used by neutrophils and monocytes are also employed by
lymphocytes. Less is known about the subsequent steps
of diapedesis and migration of leukocytes through the
basement membrane. Although elegant studies have es-
tablished clear roles for PECAM (CD31) and CD99 in
monocyte diapedesis (Muller et al., 1993; Schenkel
et al., 2002), we do not know whether these are necessary
for transmigration of lymphocytes. The mechanisms un-
derlying induction of MMP expression in T cells are even
less clear—indeed, even the requirement for MMP activity
in this process has been questioned (Wolf et al., 2003).
Several studies have suggested an important role for(F) Schematic of theMMP9 promoter showing the four putative TCF sites, one upstream pair and one downstream pair. The downstream pair is within
the 800 bp truncated promoter.
(G–K) ChIP analysis was performed by immunoprecipitation of DNA/protein complexes from effector T cells with an anti-b-catenin (G–I). DNA was
amplified with primers specific for an irrelevant sequence, 4qHox, the MMP2 promoter, and the MMP9 promoter (two sets of primers, only one is
shown). Controls were immunoprecipitated with preimmune serum. Input DNA (before immunoprecipitation) was amplified as a positive control
for the PCR. Band intensities for each of three PCR reactions were measured and immune minus preimmune intensities are plotted (J and K).
One of three similar experiments is shown.Immunity 26, 227–239, February 2007 ª2007 Elsevier Inc. 235
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Can Be Blocked by MMP-Specific
Inhibitors
(A) Effector T cells were stimulated for migra-
tion across collagen IV gels as described
above, in the presence of the control or
wnt3A-CM, with DMSO or 10 mMMMP2 inhib-
itor OA-HY. Migrated T cells were harvested
and counted. Mean and SD for triplicate wells,
*p < 0.05 (t test) for DMSO (Wnt3A) versus the
inhibitor (Wnt3A). One of three similar experi-
ments is shown.
(B) Similar to (A), except MMP inhibitor IV (10
nM) was used.Mean and SD for triplicatewells,
*p < 0.01 (t test) for DMSO (Wnt3A) versus the
inhibitor (Wnt3A). One of three similar experi-
ments is shown.VCAM-VLA-4 interactions in MMP induction during T cell
trafficking into the brain of EAE mice (Graesser et al.,
1998); however, these findings have yet to be generalized
to other vascular beds. Our results clearly demonstrate
that wnt signaling plays an important role in upregulating
MMP expression in T cells migrating into peripheral in-
flammatory sites. We propose that wnt signaling fits well
into the sequential nature of T cell extravasation: Subse-
quent to chemokine-induced firm adhesion, T cells be-
come polarized and move toward EC junctions. Either be-
fore or during diapedesis, T cells receive wnt signals from
the ECs and upregulate MMP expression. Although the
early stages of T cell extravasation are known to occur
over a time course of minutes, transit through the base-
ment membrane and into the interstitial collagen is slower,
and indeed, perivascular cuffing of T cells is a commonly
observed phenomenon in inflamed tissues (Tanaka
et al., 1975).
This delay in T cell migration probably relates to the den-
sity of the extracellular matrix (Roeder et al., 2002) and the
necessary induction of, and subsequent matrix degrading
activity of, MMPs. When MMP induction is reduced, here
by sFz5, the onward movement of the T cells through the
collagen basement membrane is also reduced, and T cells
likely recross the ECs and re-enter the circulation. Consis-
tent with this, we have observed by time-lapse video mi-
croscopy similar crossing and recrossing of an EC mono-
layer in vitro (unpublished data). An alternative explanation
for the failure to see either T cell migration or cuffing would
be that T cells are absent in the circulation; however, we
can easily rule this out because BSA-injected and sFz5-
injected tissue is harvested from opposite flanks of the
same mice. Thus, although we cannot prove this point
in vivo, the most parsimonious explanation for our data
is that T cells re-enter the circulation when further move-
ment through the basement membrane is blocked.
There appears to be considerable redundancy in wnt
signaling, as evidenced by the ability of sFz5 to block sig-
naling induced by the multiple wnts expressed by ECs.
Gene-knockout studies in mice have shown that wnt1
and wnt3A are likely to be functionally redundant (McMa-
hon and Bradley, 1990; Takada et al., 1994), and we have
treated them as such in our studies. Wnt signaling has236 Immunity 26, 227–239, February 2007 ª2007 Elsevier Inc.been shown to regulate cell movements in a number of
contexts. Noncanonical, b-catenin-independent, wnt sig-
naling through wnt5a induces actin reorganization and in-
creased cell adhesion in metastatic melanoma cells
(Weeraratna et al., 2002), whereas wnt11 induces cell po-
larity and regulates convergent extension movements in
zebrafish (Heisenberg et al., 2000). Interestingly, wnt sig-
naling has been implicated in tumor cell metastasis—
a process not unlike T cell extravasation (Kim et al.,
2002; Muller et al., 2002). Of particular relevance to the
current study, it was recently shown that invasion of mye-
loma plasma cells is promoted by wnt signaling, in this in-
stance through a pathway involving rhoA and members of
the PKC family (Qiang et al., 2005). We have previously
demonstrated in T cells the presence of a PKC-dependent
wnt pathway that controls NFAT export from the nucleus,
and we have not ruled out a role for b-catenin-indepen-
dent wnt signaling, possibly involving rac, rho, and PKC,
in T cell extravasation. Such a pathway would comple-
ment the wnt-b-catenin-MMP pathway we have de-
scribed here. Indeed, a reasonable hypothesis would be
that b-catenin-independent wnt signaling might be in-
volved in the polarization of newly adherent T cells on
the luminal surface of the ECs, whereas b-catenin-depen-
dent wnt signaling would regulate MMP expression. Cer-
tainly, chemokines have been implicated in the transition
of T cells from a nonpolarized, nonmigratory phenotype
to a phenotype specialized for directional migration; how-
ever, a role for wnts has not been excluded.
At least two MMPs have been identified as wnt targets
in non-T cells: MMP7 is downstream of b-catenin in a
human colon cancer (Crawford et al., 1999), whereas
MMP26 is a target of TCF4 in cancer cells of epithelial
origin (Marchenko et al., 2004). Here, we show that both
MMP2 and MMP9 are downstream of wnt and b-catenin
in T cells and are direct transcriptional targets of wnt sig-
naling through tandem TCF-binding sites. Consistent with
our findings, functional TCF sites have been previously
identified in the MMP7 (Matrilysin) promoter (Crawford
et al., 1999).
Several of the wnts, frizzleds, and wnt pathway genes
have been knocked out in mice and nearly all result in
embryonic or perinatal lethality, precluding analysis of
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Wnt Regulation of T Cell Migrationlymphocyte trafficking. Recently, a T cell-specific deletion
of b-catenin was reported by two groups (Cobas et al.,
2004; Xu et al., 2003). Curiously, their findings were quite
different. In one case (Cobas et al., 2004), no defect was
noted in T cell development, proliferation, or activation,
whereas in the other (Xu et al., 2003), significant defects
were seen in early T cell development, especially at the
b-selection checkpoint. In neither case was T cell traffick-
ing studied, and no explanation for these widely discrep-
ant findings has yet emerged. When it does, these mice
will likely to be proved useful in further characterizing the
role of wnts in T cell trafficking.
In conclusion, we have identified a novel role for wnt sig-
naling in regulating T cell extravasation. In the absence of
a robust wnt signal, T cells fail to upregulate MMP expres-
sion and are consequently prevented from crossing the
basement membrane and entering inflammatory tissues.
Manipulation of T cell wnt signaling may therefore be use-
ful for controlling immune inflammation.
EXPERIMENTAL PROCEDURES
Reagents
See Supplemental Experimental Procedures.
Cell Culture and Transfections
Wnt3A-producing L cells and control L cells were purchased from
ATCC. Conditioned media were obtained after 7 day culture. HUVEC
were isolated from human umbilical veins and cultured as described
previously (Hughes et al., 1990). Resting T cells were purified from hu-
man blood with the EasySep T cell enrichment kit (StemCell Technol-
ogies). This procedure yielded 98% CD3+ T cells. Effector T cells were
obtained from PBMC by stimulation with PHA (3 mg/ml) and IL-2 (25 U/
ml) for 3 days, and this was followed by growth in the presence of IL-2
(25 U/ml) for 2 days. Effector cells were typically >98% CD3+, 55%
CD4+, 40% CD8+, >90% CD25+, 20% CD69+, and <2% CD14+
or CD19+. HUVEC (p2-4) or COS-7 cells were transiently transfected
with 1 mg of DNA with Lipofectamine 2000 (Invitrogen). Resting T cells
were transiently transfected with 5 mg of DNA by Nucleofection
(Amaxa, GmbH). Effector T cells were transiently transfected with
10 mg of DNA with a Gene Pulser (Bio-Rad) at 250V, 960 mFD. All trans-
fected cells were used for experiments 24 hr later. Cotransfection
with a GFP-expressing vector showed typical efficiencies of 70%–
90% for HUVEC and COS-7 cells, 50%–60% for resting T cells,
and 30%–40% for effector T cells (see Supplemental Experimental
Procedures).
Plasmids
TOPflash and FOPflash luciferase reporters were gifts from H. Clevers
(Center of Biomedical Genetics, Utrecht, Netherlands). The wnt3A ex-
pression plasmid was fromKarl Willert (Stanford University). Truncated
LRP5 and LRP6 constructs were kindly provided by A. Brown (Weill
Medical College of Cornell University, New York, NY, USA). S33Y b-
catenin was a gift from A. Ben-Ze’ev (Weizmann Institute of Science,
Rehovot, Israel). Axin expression vector was made by cloning of
mouse Axin form 2 (a gift from F. Costantini, Columbia University,
New York, NY, USA) into pcDNA3.1(+) (Invitrogen). pcDNA-sFz5-
Flag was obtained as described previously (Salazar Murphy and
Hughes, 2002). The extracellular domain of Fz5 was cloned into the
Gateway pEmpty4 vector (Invitrogen) and then recombined into a vec-
tor that adds the mouse IgG2a-Fc (pDEST-Ig, created in our lab).
MMP2 andMMP9 partial promoters were cloned from human genomic
DNA by PCR and inserted into the pGl3e luciferase reporter vector
(Promega). The putative TCF sites in the MMP2 promoter were mu-
tated by PCR from 50-CTTTGC-30 to 50-CCCTGC-30 (upstream;Immutated section indicated by underline) and from 50-CTTTGT-30 to
50-CCCTGG-30 (downstream). The two TCF sites in a truncated (800
bp) MMP9 proximal promoter were mutated from 50-TCAAAG-30 to
50-GCGCAG-30 (both upstream and downstream). The site-directed
mutagenesis was performed with the QuickChange XL from Strata-
gene.
RT-PCR
See Supplemental Experimental Procedures.
Protein Purification
See Supplemental Experimental Procedures.
In Vitro T Cell-Transmigration Assay
For transendothelial migration, HUVEC were plated in triplicate on the
upper wells of 24-well collagen-coated 3 mmCostar transwells (Fisher)
and grown to confluence. Cells were then treated with TNFa (10 ng/ml)
for 4 hr for upregulating expression of adhesion molecules. Human
SDF1a was added to the lower wells at 100 ng/ml, and effector T cells
were added to the upper wells. After 24 hr, T cells that had transmi-
grated into the lower wells were collected and counted. For some ex-
periments, effector T cells were added to the upper wells of 24-well
collagen I-coated or collagen IV-coated transwells in the absence of
ECs.Wnt3A-CMor control mediumwas then added to the upper wells.
T Cell Infiltration into Inflamed Tissue In Vivo
Female BALB/c mice were obtained from Jackson Laboratories. Mice
were used at 6–10 weeks of age. All mouse experiments were per-
formed according to protocols approved by the Institutional Animal
Care and Use Committee of UCI. Mice were anesthetized with ket-
amine and xylazine. The backs were shaved and each of five mice
was injected i.d. in eight patches on the back with 10 ml, in duplicate,
of diluent alone (13 HBSS), cytokines (10 ng TNFa + 300 U IFNg), cy-
tokines with sFz5-Fc protein (1 mg), or cytokines with BSA control pro-
tein (1 mg). After 22 hr, skin was harvested and frozen. Frozen sections
at 5 mm thick were fixed with acetone and stained with hamster anti-
mouse CD3 (10 mg/ml) and then Alexa 488-conjugated goat anti-ham-
ster IgG, and biotin-anti-CD31 (5 mg/ml) together with Texas-
red-Streptavidin (1:200) and DAPI. The number of infiltrating T cells
was analyzed with NIH Image J software.
ChIP Assay
ChIP analysis was performed according to the manufacturer’s proto-
col (Upstate Biotechnology). Effector T cells (33 106) were harvested,
and DNA was precipitated with 20 mg of polyclonal anti-b-catenin
(Santa Cruz) or a preimmune rabbit IgG antibody as a negative control.
Precipitated DNA was amplified with the following primer sets: for the
MMP2 promoter, 50-GAGGTCGCTTTCTTTGCCATCT-30 (upper) and
50-AGCGACTCCATCTTG AACAGG-30 (lower); for the MMP9 promoter
#1, 50-AAGTTAATTATCTCCATCTC ACAGTCTCAT-30 (upper) and 50-
CGGCATCGGGCAGGGTCT-30 (lower); and for the MMP9 promoter
#2, 50-CACTGTATCCTTGACCTTCTTTCTGG-30 (upper) and 50-
GCTTCCTCTCCCTGCTTCATCTG-30 (lower). PCR signal intensity
was analyzed with the Quantity One program from Bio-Rad.
Statistical Analysis
Data are represented as mean ± SD. Student’s t test (Microsoft Excel)
was used for analyzing differences between experimental groups as
indicated in the figure legends. A p value of less than 0.05 was consid-
ered significant. Unless indicated otherwise, all experiments were per-
formed at least three times with similar results.
Supplemental Data
Supplemental Data include Experimental Procedures and five figures
and are available with this article online at http://www.immunity.
com/cgi/content/26/2/227/DC1/.munity 26, 227–239, February 2007 ª2007 Elsevier Inc. 237
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